FDA Puts Limits On Reprints Of Drug Risk Research
The U.S. Food and Drug Administration on Friday spelled out numerous conditions that apply if drugmakers distribute new research that calls into question a product's perceived risks, requiring manufacturers to tread...To view the full article, register now.
Already a subscriber? Click here to view full article